Details for New Drug Application (NDA): 205004
✉ Email this page to a colleague
The generic ingredient in BORTEZOMIB is bortezomib. There are twenty drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the bortezomib profile page.
Summary for 205004
Tradename: | BORTEZOMIB |
Applicant: | Fresenius Kabi Usa |
Ingredient: | bortezomib |
Patents: | 1 |
Medical Subject Heading (MeSH) Categories for 205004
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | POWDER;INTRAVENOUS | Strength | 3.5MG/VIAL | ||||
Approval Date: | Nov 6, 2017 | TE: | RLD: | No | |||||
Patent: | ⤷ Sign Up | Patent Expiration: | Nov 3, 2032 | Product Flag? | Y | Substance Flag? | Delist Request? |
Complete Access Available with Subscription